Table of contents
A Quick Look Back At Stock Performance 3
Our Views On The Stocks 5
1Q09 Earnings Takeaways: Sales & Earnings Decelerating 7
Medicare Hospital Inpatient Payment Proposal 8
Healthcare Reform Updates 11
Calendar of Events 12
A Closer Look At Stock Performance 16
S&P 500 Sector Performance 17
S&P 500 Healthcare 19
MedTech Valuations 23
Sector Valuation 24
Other Topics 27
Short Interest Positions 28
Foreign Exchange Rate Movements Adds Volatility 29
Macro Economic Spill Over Effects Evident 33
Company Profiles and Earnings Preview/Reviews 34
Bard (BCR-Neutral) 35
Baxter International (BAX-Neutral) 46
Becton Dickinson (BDX-Outperform) 63
Boston Scientific (BSX-Neutral) 78
Covidien (COV-Outperform) 90
Edwards Lifesciences (EW-Outperform) 105
Medtronic (MDT-Neutral) 116
Nanosphere (NSPH-Outperform) 132
St. Jude Medical (STJ-Neutral) 137
Stryker (SYK-Neutral) 149
Zimmer Holdings (ZMH-Neutral) 160
Major Product Categories 173
Cardiac Rhythm Management (CRM) 174
Coronary Stents 184
Heart Valves 188
Blood Plasma Market 195
Glossary 196
C. R. Bard, Inc. BCR 199
Baxter International BAX 200
Becton Dickinson & Co. BDX 201
Boston Scientific Corp. BSX 202
Covidien COV 203
Edwards Lifesciences Corp. EW 204
Medtronic MDT 205
Nanosphere NSPH 206
St. Jude Medical STJ 207
Stryker Corporation SYK 208
Zimmer Holdings, Inc. ZMH 209